LATS2 and colorectal carcinoma: Taken together, these data demonstrated that LATS2 is involved in the suppressive effects of 5’tiRNA-His-GTG inhibition on CRC cells; however, the role of 5’tiRNA-His-GTG in CRC is not completely dependent on LATS2.